|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7450 AUD | -1.97% |
|
-11.83% | -31.34% |
| 15/07 | Orthocell June Quarter Highlights Strong Revenue Growth, Euroz Hartleys Says | MT |
| 13/07 | Orthocell Says June Quarter Revenue Rises 36% Year-over-Year to New Record | MT |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -34.21 | -25.17 | -19.04 | -25.04 | -26.42 | |||||
Return on Total Capital | -37.37 | -51.61 | -75.04 | -117.99 | -80.22 | |||||
Return On Equity % | -47.84 | -68.01 | -77.84 | -134.46 | -89.7 | |||||
Return on Common Equity | -47.84 | -68.01 | -77.84 | -134.46 | -89.7 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 38.54 | 54.13 | 75.82 | 69.39 | 63.63 | |||||
SG&A Margin | 463.5 | 361.39 | 140.45 | 125.96 | 124.68 | |||||
EBITDA Margin % | -1.11T | -737.55 | -233.91 | -205.25 | -168.14 | |||||
EBITA Margin % | -1.12T | -744.94 | -239.57 | -209.88 | -171.66 | |||||
EBIT Margin % | -1.14T | -752.21 | -242.28 | -211.92 | -173.12 | |||||
Income From Continuing Operations Margin % | -887.76 | -594.53 | -147.26 | -135.1 | -113.46 | |||||
Net Income Margin % | -887.76 | -594.53 | -147.26 | -135.1 | -113.46 | |||||
Net Avail. For Common Margin % | -887.76 | -594.53 | -147.26 | -135.1 | -113.46 | |||||
Normalized Net Income Margin | -701.86 | -459.07 | -138.62 | -120.32 | -97.27 | |||||
Levered Free Cash Flow Margin | -298.32 | -1.67T | 373.22 | -92.3 | -81.85 | |||||
Unlevered Free Cash Flow Margin | -298.32 | -1.67T | 373.22 | -92.3 | -81.85 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.05 | 0.05 | 0.13 | 0.19 | 0.24 | |||||
Fixed Assets Turnover | 1.22 | 1.31 | 2.82 | 2.55 | 3.09 | |||||
Receivables Turnover (Average Receivables) | 8.77 | 0.13 | 0.36 | 9.9 | 7.85 | |||||
Inventory Turnover (Average Inventory) | 2.42 | 1.3 | 1.25 | 1.47 | 2.31 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 8.83 | 5.17 | 5.93 | 4.34 | 4.97 | |||||
Quick Ratio | 8.58 | 5.07 | 5.66 | 4.11 | 4.76 | |||||
Operating Cash Flow to Current Liabilities | -2.4 | -0.92 | 3.22 | -1.23 | -1.36 | |||||
Days Sales Outstanding (Average Receivables) | 41.61 | 2.81T | 1.03T | 36.97 | 46.51 | |||||
Days Outstanding Inventory (Average Inventory) | 150.64 | 281.16 | 293.04 | 248.67 | 158.16 | |||||
Average Days Payable Outstanding | 293.31 | 899.26 | 524.54 | 230.56 | 200.29 | |||||
Cash Conversion Cycle (Average Days) | -101.06 | 2.19T | 796.55 | 55.07 | 4.38 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 3.68 | 5.12 | 9.14 | 15.22 | 3.96 | |||||
Total Debt / Total Capital | 3.55 | 4.87 | 8.38 | 13.21 | 3.81 | |||||
LT Debt/Equity | 3.01 | 3.91 | 6.21 | 11.93 | 2.82 | |||||
Long-Term Debt / Total Capital | 2.9 | 3.72 | 5.69 | 10.35 | 2.72 | |||||
Total Liabilities / Total Assets | 12.71 | 73.86 | 79.23 | 82.97 | 58.65 | |||||
Total Debt / EBITDA | -0.06 | -0.05 | -0.06 | -0.06 | -0.05 | |||||
Net Debt / EBITDA | 1.4 | 0.94 | 2.49 | 1.85 | 2.24 | |||||
Total Debt / (EBITDA - Capex) | -0.05 | -0.04 | -0.05 | -0.06 | -0.05 | |||||
Net Debt / (EBITDA - Capex) | 1.38 | 0.9 | 2.35 | 1.71 | 2.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 41.48 | 50.47 | 177.01 | 25.27 | 42.05 | |||||
Gross Profit, 1 Yr. Growth % | 83.2 | 111.34 | 288 | 14.66 | 30.27 | |||||
EBITDA, 1 Yr. Growth % | 26.75 | 0.01 | -12.15 | 9.92 | 16.37 | |||||
EBITA, 1 Yr. Growth % | 26.74 | 0.35 | -10.91 | 9.75 | 16.18 | |||||
EBIT, 1 Yr. Growth % | 26.81 | -0.94 | -10.78 | 9.57 | 16.05 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 46.92 | 0.77 | -31.39 | 14.93 | 19.3 | |||||
Net Income, 1 Yr. Growth % | 46.92 | 0.77 | -31.39 | 14.93 | 19.3 | |||||
Normalized Net Income, 1 Yr. Growth % | 26.24 | -1.58 | -16.35 | 8.73 | 14.85 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 34.34 | -2.82 | -31.91 | 12.5 | 6.59 | |||||
Accounts Receivable, 1 Yr. Growth % | 248.07 | 12.89T | -97.98 | 26.59 | 120.76 | |||||
Inventory, 1 Yr. Growth % | 886.05 | 30.86 | 68.54 | 13.78 | 2.23 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 27.05 | 50.03 | 14.56 | 59.51 | -9.04 | |||||
Total Assets, 1 Yr. Growth % | -16.57 | 96.04 | -21.88 | -10.1 | 32.39 | |||||
Tangible Book Value, 1 Yr. Growth % | -19.32 | -44.22 | -42.18 | -30.49 | 287.12 | |||||
Common Equity, 1 Yr. Growth % | -19.27 | -41.3 | -37.92 | -26.29 | 221.43 | |||||
Cash From Operations, 1 Yr. Growth % | -11.86 | 38.59 | -333.05 | -144.58 | 33.48 | |||||
Capital Expenditures, 1 Yr. Growth % | 2.01T | 238.33 | 18.61 | 51.1 | -71.9 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -38.58 | 739.93 | -162.08 | -130.98 | 25.97 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -38.58 | 739.93 | -162.08 | -130.98 | 25.97 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.75 | 45.9 | 104.16 | 86.28 | 33.4 | |||||
Gross Profit, 2 Yr. CAGR % | 35.61 | 96.76 | 186.35 | 110.92 | 22.21 | |||||
EBITDA, 2 Yr. CAGR % | 16.68 | 12.59 | -6.26 | -1.73 | 13.1 | |||||
EBITA, 2 Yr. CAGR % | 16.6 | 12.78 | -5.45 | -1.12 | 12.92 | |||||
EBIT, 2 Yr. CAGR % | 16.86 | 12.08 | -5.99 | -1.12 | 12.76 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 24.27 | 21.68 | -16.85 | -11.2 | 17.09 | |||||
Net Income, 2 Yr. CAGR % | 24.27 | 21.68 | -16.85 | -11.2 | 17.09 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.93 | 11.46 | -9.27 | -4.63 | 11.75 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.09 | 14.26 | -18.66 | -12.48 | 9.5 | |||||
Accounts Receivable, 2 Yr. CAGR % | 54.91 | 2.03T | 62.12 | -84 | 67.17 | |||||
Inventory, 2 Yr. CAGR % | 192.96 | 259.21 | 48.51 | 38.48 | 7.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 80.38 | 38.06 | 31.1 | 35.18 | 20.45 | |||||
Total Assets, 2 Yr. CAGR % | 19.23 | 27.89 | 23.76 | -16.2 | 9.1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 31.87 | -32.91 | -43.21 | -36.6 | 64.04 | |||||
Common Equity, 2 Yr. CAGR % | 25.44 | -31.16 | -39.63 | -32.35 | 53.93 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.28 | 9.14 | 79.72 | 1.93 | -22.86 | |||||
Capital Expenditures, 2 Yr. CAGR % | 228.63 | 744.03 | 100.32 | 33.87 | -34.84 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -9.28 | 127.13 | 128.36 | -56.14 | -37.53 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -9.28 | 127.13 | 128.36 | -56.14 | -37.53 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 18.02 | 17.44 | 80.67 | 73.49 | 70.19 | |||||
Gross Profit, 3 Yr. CAGR % | 38 | 57.23 | 146.74 | 111.06 | 79.62 | |||||
EBITDA, 3 Yr. CAGR % | 12.95 | 10.83 | 3.66 | -1.15 | 3.97 | |||||
EBITA, 3 Yr. CAGR % | 12.84 | 10.91 | 4.25 | -0.63 | 4.34 | |||||
EBIT, 3 Yr. CAGR % | 13.14 | 10.6 | 3.88 | -1.06 | 4.3 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.22 | 15.88 | 0.52 | -7.38 | -2.02 | |||||
Net Income, 3 Yr. CAGR % | 16.22 | 15.88 | 0.52 | -7.38 | -2.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.59 | 9.77 | 1.29 | -3.63 | 1.46 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -4.19 | -1.67 | -3.85 | -9.37 | -6.54 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17.55 | 578.11 | 109.14 | 49.29 | -61.62 | |||||
Inventory, 3 Yr. CAGR % | 105.77 | 123.95 | 179.13 | 35.89 | 25.16 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 39.93 | 69.64 | 29.73 | 39.96 | 18.45 | |||||
Total Assets, 3 Yr. CAGR % | 54.61 | 40.73 | 8.51 | 11.25 | -2.4 | |||||
Tangible Book Value, 3 Yr. CAGR % | 179.48 | -1.01 | -36.16 | -39.25 | 15.87 | |||||
Common Equity, 3 Yr. CAGR % | 92.32 | -2.62 | -33.49 | -35.48 | 13.73 | |||||
Cash From Operations, 3 Yr. CAGR % | -0.08 | 14.42 | 40.54 | 12.92 | 11.51 | |||||
Capital Expenditures, 3 Yr. CAGR % | 20.59 | 231.83 | 338.81 | 82.35 | -20.44 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -10.19 | 90.5 | 47.4 | 17.34 | -37.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -10.19 | 90.5 | 47.4 | 17.34 | -37.66 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.84 | 23.65 | 46.95 | 41.24 | 60.03 | |||||
Gross Profit, 5 Yr. CAGR % | 18.36 | 55.33 | 84.79 | 76.83 | 86.29 | |||||
EBITDA, 5 Yr. CAGR % | 16.54 | 13.43 | 4.83 | 5.63 | 7.33 | |||||
EBITA, 5 Yr. CAGR % | 16.48 | 13.39 | 5.13 | 5.93 | 7.64 | |||||
EBIT, 5 Yr. CAGR % | 16.78 | 13.32 | 5.06 | 5.75 | 7.34 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.01 | 16.87 | 1.65 | 4.18 | 6.85 | |||||
Net Income, 5 Yr. CAGR % | 19.01 | 16.87 | 1.65 | 4.18 | 6.85 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.65 | 12.93 | 3.28 | 3.77 | 5.35 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.37 | 1.75 | -10.27 | -6.15 | 1.28 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.45 | 265.92 | 33.68 | 51.51 | 91.22 | |||||
Inventory, 5 Yr. CAGR % | 28.44 | 47.33 | 80.61 | 84.77 | 90.82 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 26.44 | 31.41 | 36.33 | 54.91 | 25.94 | |||||
Total Assets, 5 Yr. CAGR % | 22.13 | 39.56 | 41.44 | 14.38 | 8.75 | |||||
Tangible Book Value, 5 Yr. CAGR % | 33.84 | 22.1 | 47.75 | -17.17 | -6.88 | |||||
Common Equity, 5 Yr. CAGR % | 28.14 | 16.02 | 20.98 | -15.82 | -6.97 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.89 | 11.98 | 25.73 | 9.25 | 10.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | 30.14 | 36.8 | 47.73 | 130.79 | 104.62 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -0.38 | 50.1 | 30.45 | 5.86 | 4.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -0.38 | 50.1 | 30.45 | 5.86 | 4.56 |
- Stock Market
- Stocks
- OCC Stock
- Financials Orthocell Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















